In today’s recent session, 1.91 million shares of the Syndax Pharmaceuticals Inc (NASDAQ:SNDX) have been traded, and its beta is 0.86. Most recently the company’s share price was $11.76, and it changed around -$1.81 or -13.35% from the last close, which brings the market valuation of the company to $1.01B. SNDX at last check was trading at a discount to its 52-week high of $25.07, offering almost -113.18% off that amount. The share price’s 52-week low was $9.66, which indicates that the recent value has risen by an impressive 17.86% since then.
Syndax Pharmaceuticals Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.23. If we narrow it down even further, the data shows that 0 out of 13 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 1 recommended SNDX as a Hold, whereas 9 deemed it a Buy, and 0 rated it as Underweight.
Syndax Pharmaceuticals Inc (NASDAQ:SNDX) trade information
Instantly SNDX has been showing red trend so far today with a performance of -13.35% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 14.24 on recent trading dayincreased the stock’s daily price by 17.42%. The company’s shares are currently down -11.05% year-to-date, but still down -14.17% over the last five days. On the other hand, Syndax Pharmaceuticals Inc (NASDAQ:SNDX) is 4.52% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $18, which translates to bulls needing to increase their stock price by 34.67% from its current value. Analyst projections state that SNDX is forecast to be at a low of $18 and a high of $18.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -15.16%. Syndax Pharmaceuticals Inc earnings are expected to increase by 0.46% in 2025, but the outlook is positive 28.15% per year for the next five years.
SNDX Dividends
Syndax Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in June.
WELLINGTON MANAGEMENT GROUP LLP, with 8.6063% or 7.34 million shares worth $150.67 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Jan 31, 2025 . The former held 2.99 shares worth $34.53 million, making up 3.47% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 2.55 shares worth around $29.51 million, which represents about 2.97% of the total shares outstanding.
